Sun Pharma Announces Data From First-in-Human Phase 1 Studies Of GL0034 At American Diabetes Association
The data will be highlighted in poster presentations at the American Diabetes Association’s (ADA) 83rd Scientific Sessions held from June 23-26, 2023, in San Diego, CA.
Source: freepressjournal.in